Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-12-23
|
pubmed:abstractText |
In a cross-sectional study of 33 workers exposed to benzidine and benzidine dyes and 15 non-exposed controls, we previously reported that exposure status and internal dose of benzidine metabolites were strongly correlated with the levels of specific benzidine-DNA adducts in exfoliated urothelial cells. We also evaluated DNA adduct levels in peripheral white blood cells (WBC) of a subset of 18 exposed workers and 7 controls selected to represent a wide range of adducts in exfoliated urothelial cells. Samples were coded and then DNA was analyzed using 32P-postlabeling, along with n-butanol extraction. One adduct, which co-chromatographed with a synthetic N-(3'-phospho-deoxyguanosin-8-yl)-N'-acetylbenzidine standard, predominated in those samples with adducts present. The median level (range) of this adduct in WBC DNA was 194.4 (3.2-975) RAL x 10(9) in exposed workers and 1.4 (0.1-6.4) in the control subjects (p = 0.0002, Wilcoxon Rank Sum Test). There was a striking correlation between WBC and exfoliated urothelial cell adduct levels (Pearson r = 0.84, p < 0.001) among exposed subjects. In addition, the sum of urinary benzidine, N-acetylbenzidine and N,N'-diacetylbenzidine correlated with the levels of this adduct in both tissues. This is the first study in humans to show a relationship for a specific carcinogen adduct in a surrogate tissue and in urothelial cells, the target for urinary bladder cancer.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0027-5107
|
pubmed:author |
pubmed-author:BhatnagarV KVK,
pubmed-author:DavisBB,
pubmed-author:DosemeciMM,
pubmed-author:HayesR BRB,
pubmed-author:HsuF FFF,
pubmed-author:JaegerMM,
pubmed-author:KashyapRR,
pubmed-author:KashyapS KSK,
pubmed-author:LakshmiV MVM,
pubmed-author:ParikhD JDJ,
pubmed-author:RothmanNN,
pubmed-author:TalaskaGG,
pubmed-author:ZenzerT VTV,
pubmed-author:ZhouQQ
|
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
393
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
199-205
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9393612-Adult,
pubmed-meshheading:9393612-Benzidines,
pubmed-meshheading:9393612-Cross-Sectional Studies,
pubmed-meshheading:9393612-DNA Adducts,
pubmed-meshheading:9393612-Humans,
pubmed-meshheading:9393612-India,
pubmed-meshheading:9393612-Leukocytes,
pubmed-meshheading:9393612-Occupational Exposure,
pubmed-meshheading:9393612-Urinary Bladder Neoplasms,
pubmed-meshheading:9393612-Urothelium
|
pubmed:year |
1997
|
pubmed:articleTitle |
Benzidine-DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells.
|
pubmed:affiliation |
Department of Environmental Health, University of Cincinnati, OH 45267-0056, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|